MedPath

Incremental infusion of atrial natriuretic peptide suppresses leptin secretion in healthy men.

Not Applicable
Conditions
Hyperleptinemia
Registration Number
DRKS00024559
Lead Sponsor
Deutsches Zentrum für Luft- und Raumfahrt (DLR)Institut für Luft- und Raumfahrtmedizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
17
Inclusion Criteria

BMI 20-25 kg/m2
No medication

Exclusion Criteria

BMI < 20 or > 25 kg/m2
Any medication

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in serum Leptin concentration over 135 min, measured by ELISA
Secondary Outcome Measures
NameTimeMethod
Change in concentrations of RBP4, Resistin, Visfatin, ANP, free fatty acids, glucose and glycerol in Serum over 135 min
© Copyright 2025. All Rights Reserved by MedPath